Literature DB >> 18216783

Cell cycle control of centromeric repeat transcription and heterochromatin assembly.

Ee Sin Chen1, Ke Zhang, Estelle Nicolas, Hugh P Cam, Martin Zofall, Shiv I S Grewal.   

Abstract

Heterochromatin in eukaryotic genomes regulates diverse chromosomal processes including transcriptional silencing. However, in Schizosaccharomyces pombe RNA polymerase II (RNAPII) transcription of centromeric repeats is essential for RNA-interference-mediated heterochromatin assembly. Here we study heterochromatin dynamics during the cell cycle and its effect on RNAPII transcription. We describe a brief period during the S phase of the cell cycle in which RNAPII preferentially transcribes centromeric repeats. This period is enforced by heterochromatin, which restricts RNAPII accessibility at centromeric repeats for most of the cell cycle. RNAPII transcription during S phase is linked to loading of RNA interference and heterochromatin factors such as the Ago1 subunit of the RITS complex and the Clr4 methyltransferase complex subunit Rik1 (ref. 7). Moreover, Set2, an RNAPII-associated methyltransferase that methylates histone H3 lysine 36 at repeat loci during S phase, acts in a pathway parallel to Clr4 to promote heterochromatin assembly. We also show that phosphorylation of histone H3 serine 10 alters heterochromatin during mitosis, correlating with recruitment of condensin that affects silencing of centromeric repeats. Our analyses suggest at least two distinct modes of heterochromatin targeting to centromeric repeats, whereby RNAPII transcription of repeats and chromodomain proteins bound to methylated histone H3 lysine 9 mediate recruitment of silencing factors. Together, these processes probably facilitate heterochromatin maintenance through successive cell divisions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18216783     DOI: 10.1038/nature06561

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  202 in total

1.  Chromatin maintenance by a molecular motor protein.

Authors:  Manjari Mazumdar; Myong-Hee Sung; Tom Misteli
Journal:  Nucleus       Date:  2011-11-01       Impact factor: 4.197

2.  A model for mitotic inheritance of histone lysine methylation.

Authors:  Mo Xu; Weixiang Wang; She Chen; Bing Zhu
Journal:  EMBO Rep       Date:  2011-12-23       Impact factor: 8.807

3.  Heterochromatin protein 1 homologue Swi6 acts in concert with Ers1 to regulate RNAi-directed heterochromatin assembly.

Authors:  Aki Hayashi; Mayumi Ishida; Rika Kawaguchi; Takeshi Urano; Yota Murakami; Jun-ichi Nakayama
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

Review 4.  Chromatin replication and epigenome maintenance.

Authors:  Constance Alabert; Anja Groth
Journal:  Nat Rev Mol Cell Biol       Date:  2012-02-23       Impact factor: 94.444

Review 5.  Pericentric and centromeric transcription: a perfect balance required.

Authors:  Laura E Hall; Sarah E Mitchell; Rachel J O'Neill
Journal:  Chromosome Res       Date:  2012-07       Impact factor: 5.239

Review 6.  Ancestral roles of small RNAs: an Ago-centric perspective.

Authors:  Leemor Joshua-Tor; Gregory J Hannon
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-10-01       Impact factor: 10.005

Review 7.  A lot about a little dot - lessons learned from Drosophila melanogaster chromosome 4.

Authors:  Nicole C Riddle; Christopher D Shaffer; Sarah C R Elgin
Journal:  Biochem Cell Biol       Date:  2009-02       Impact factor: 3.626

Review 8.  Small RNAs as guardians of the genome.

Authors:  Colin D Malone; Gregory J Hannon
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

Review 9.  Role of chromatin states in transcriptional memory.

Authors:  Sharmistha Kundu; Craig L Peterson
Journal:  Biochim Biophys Acta       Date:  2009-02-21

Review 10.  RNA interference in the nucleus: roles for small RNAs in transcription, epigenetics and beyond.

Authors:  Stephane E Castel; Robert A Martienssen
Journal:  Nat Rev Genet       Date:  2013-02       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.